A detailed history of Sherbrooke Park Advisers LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 10,308 shares of GMED stock, worth $754,545. This represents 0.27% of its overall portfolio holdings.

Number of Shares
10,308
Holding current value
$754,545
% of portfolio
0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$69.79 - $85.61 $719,395 - $882,467
10,308 New
10,308 $853 Million
Q2 2023

Aug 14, 2023

BUY
$52.61 - $59.54 $52,610 - $59,540
1,000 Added 22.73%
5,400 $322 Million
Q1 2023

May 15, 2023

BUY
$51.83 - $79.63 $20,732 - $31,852
400 Added 10.0%
4,400 $249 Million
Q4 2022

Feb 14, 2023

BUY
$58.4 - $75.53 $233,600 - $302,120
4,000 New
4,000 $297 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $5.64B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.